[1]刘宝珍,薛春霞,金世禄.肠道菌群与消化系疾病[J]. 内蒙古中医药,2011,30(3):86-88.
[2]郎媛媛.益生菌降低肿瘤发生率 [J].中国保健营养,2015(2): 74-75.
[3]de WINTERB Y, de MAN J G.Interplay between inflammation, immune system and neuronal pathways: Effect on gastrointestinal motility [J]. Word J Gastroenterol, 2010, 16 (44):5523-5535.
[4]LEE AL, KIM CB.The effect of erythromycin on gastrointestinal motility in subtotal gastrectomized patients [J].J Korean Surg Soc, 2012, 82(3):149-155.
[6]李伟. 功能性低聚糖的酶法合成及其生理功能评价[D].南京:南京农业大学,2010.
[7]丁晓雯,周才琼.保健食品原理[M].重庆:西南师范大学出版社,2008:179-180.
[8]王良东.低聚异麦芽糖性质、功能、生产和应用[J].粮食与油脂, 2008 (4): 43-47.
[9]刘晓梅,彭芝榕,倪学勤,等.低聚果糖、乳酸杆菌对便秘模型大鼠的通便功能影响[J].食品科学, 2013,34 (11) : 296-299.
[10]姚景会,冉陆,李志刚,等.异麦芽低聚糖调节肠道菌群作用的研究[J].中国食品卫生杂志.1999, 1(2): 6-8.
[11]KARI G, RODECK U, DICKLER A P.Zebrafish: an emerging model system for human disease and drug discovery [J].Clinical Pharmacology & Therapeutics, 2007, 82(1):70-80.
[12]PENBERTHY W T, SHAFIZADEH E, LIN S.The zebrafish as a model for human disease [J]. Front Biosci, 2002, 7:d1439-1453.
[13]李淼.地塞米松磷酸钠导致斑马鱼颅面部发育异常的研究[D].武汉:华中科技大学,2009.
[14]RICH A. A new highcontent model system for studies of gastrointestinal transit:the zebrafish [J].Neurogastroenterol Motil, 2009, 21 (3): 225-228.
[15]WESTERFIELD M, WEGNER J, JEGALIAN B G, et al. Specific activation of mammalian Hox promoters in mosaic transgenic zebrafish [J]. Genes Dev, 1992, 6( 4) : 591-598.
[16]王良东,陈建文,吴嘉麟.功能性低聚糖制备[J].粮食与油脂, 2008 (7): 38-42.
[17]李茂龄.低聚异麦芽糖的生理功能研究[J].中国食品添加剂,2002 (2): 37-39.
[18]COWAN A, EARNEST D L, LIGOZIO G, et al. Omeprazoleinduced slowing of gastrointestinal transit in mice can be countered with tegaserod [J].European Journal of Pharmacology, 2005,517 (1/2):127-131.
|